Review



next generation 320 sequencing based test  (Foundation Medicine Inc)


Bioz Verified Symbol Foundation Medicine Inc is a verified supplier
Bioz Manufacturer Symbol Foundation Medicine Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    Foundation Medicine Inc next generation 320 sequencing based test
    Next Generation 320 Sequencing Based Test, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 2432 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/FoundationOne+CDx/pm40973032-82-3-9
    Average 99 stars, based on 2432 article reviews
    next generation 320 sequencing based test - by Bioz Stars, 2026-11
    99/100 stars

    Images

    Related Articles

    Next-Generation Sequencing:

    Article Title: Precision medicine in patients with advanced biliary tract cancer.
    Article Snippet: .. Internal/academic (e.g., MOSCATO 01/02 [22,23], MATCH-R [24,25], SHIVA [26] , BOB [NCT03767075]) or commercial next-generation sequencing (NGS) panels (e.g., FoundationOneCDx and FoundationOneLiquid CDx [Foundation Medicine; Cambridge, MA], Oncomine Comprehensive Assay v1/v3 and Oncomine Comprehensive Assay Plus [Thermo Fisher Scientific; Waltham, MA, USA]; Guardant 360 CDx [Guardant Health; Redwood City, CA]) were used; DNA and/or ribonucleic acid were examined, with 11 to 1056 genes analyzed depending on the panel used for point mutations, deletions, insertions, copy number variants and fusions/rearrangements (Supplementary Table 1). ..

    Analysis:

    Article Title: Multicenter Evaluation of Decentralized Homologous Recombination Deficiency Testing for Enhanced Molecular Diagnosis of Ovarian Cancer †
    Article Snippet: .. Tempus xT CDx (Tempus AI, Inc., USA), the most recently approved test for tumor-only indication [ ], and FoundationOne CDx and Foundation One Liquid CDx for cell-free DNA analysis (Foundation Medicine, USA) focus on genomic LOH and microsatellite instability (MSI). .. In contrast, Myriad MyChoice CDx HRD (hereafter referred to as M-HRD) (Myriad Genetics; USA) evaluates all three genomic scars [ , , ].

    Profiling:

    Article Title: Optimal Genetic Profiling in Sarcoma Requires Quality Control and Comparative Studies
    Article Snippet: G enomic profiling in sarcomas is a relatively new technology that has important implications for the treatment of this heterogeneous group of tumors 1 .. It has led to the possibility of not only further classifying or diagnosing sarcoma subtypes but also identifying targetable alterations 2 .. This has led to a shift in management such that multiple sarcomas now have a viable medical treatment option where none was previously available.



    Similar Products

    99
    Foundation Medicine Inc next generation sequencing based test
    Next Generation Sequencing Based Test, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/FoundationOne+CDx/pmc12578505-138-3-8
    Average 99 stars, based on 1 article reviews
    next generation sequencing based test - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    99
    Foundation Medicine Inc next generation 320 sequencing based test
    Next Generation 320 Sequencing Based Test, supplied by Foundation Medicine Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/FoundationOne+CDx/pm40973032-82-3-9
    Average 99 stars, based on 1 article reviews
    next generation 320 sequencing based test - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    90
    Natera Inc next-generation sequencing–based 385 kidney gene panel renasighttm test
    Next Generation Sequencing–Based 385 Kidney Gene Panel Renasighttm Test, supplied by Natera Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/renasight+multigene+panel+for+kidney+disease/pmc12129528-69-6-15
    Average 90 stars, based on 1 article reviews
    next-generation sequencing–based 385 kidney gene panel renasighttm test - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Illumina Inc amplicon-based next-generation sequencing (ngs) test miseq
    Amplicon Based Next Generation Sequencing (Ngs) Test Miseq, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/high+throughput+amplicon+sequencing/pm40359709-45-12-17
    Average 90 stars, based on 1 article reviews
    amplicon-based next-generation sequencing (ngs) test miseq - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Natera Inc next-generation sequencing-based genetic testing renasighttm
    Next Generation Sequencing Based Genetic Testing Renasighttm, supplied by Natera Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/renasight+multigene+panel+for+kidney+disease/pm40057195-42-11-12
    Average 90 stars, based on 1 article reviews
    next-generation sequencing-based genetic testing renasighttm - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Karius Inc blood-based test utilizing next generation sequencing for detection of microbial cell free dna
    Blood Based Test Utilizing Next Generation Sequencing For Detection Of Microbial Cell Free Dna, supplied by Karius Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/microbial+cell+free+dna+next+generation+sequencing+test/10__1097_slash_icb__0000000000001736-47-17-26
    Average 90 stars, based on 1 article reviews
    blood-based test utilizing next generation sequencing for detection of microbial cell free dna - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Natera Inc next-generation sequencing–based, noninvasive prenatal cell-free dna test fetal rhd genotype
    <t> Prenatal </t> cell-Free DNA <t> RHD </t> Assay Results Compared With Serologic Truth
    Next Generation Sequencing–Based, Noninvasive Prenatal Cell Free Dna Test Fetal Rhd Genotype, supplied by Natera Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/snp+based+nipt/pmc11731044-15-10-15
    Average 90 stars, based on 1 article reviews
    next-generation sequencing–based, noninvasive prenatal cell-free dna test fetal rhd genotype - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    90
    Myriad Genetics mychoice® cdx next-generation sequencing-based tumor test
    <t> Prenatal </t> cell-Free DNA <t> RHD </t> Assay Results Compared With Serologic Truth
    Mychoice® Cdx Next Generation Sequencing Based Tumor Test, supplied by Myriad Genetics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/next+generation+sequencing+based+test/mychoice+cdx/pm39695768-51-18-22
    Average 90 stars, based on 1 article reviews
    mychoice® cdx next-generation sequencing-based tumor test - by Bioz Stars, 2026-11
    90/100 stars
      Buy from Supplier

    Image Search Results


    Journal: Obstetrics and Gynecology

    Article Title: Clinical Validation of a Prenatal Cell-Free DNA Screening Test for Fetal RHD in a Large U.S. Cohort

    doi: 10.1097/AOG.0000000000005794

    Figure Lengend Snippet: Prenatal cell-Free DNA RHD Assay Results Compared With Serologic Truth

    Article Snippet: A next-generation sequencing–based, noninvasive prenatal cell-free DNA test for fetal RHD genotype was developed by Natera, Inc. for use in pregnant patients with an RhD-negative phenotype.

    Techniques: